News Focus
News Focus
icon url

tob999

10/29/16 8:32 AM

#78922 RE: Diamondhands45 #78916

I only go by the statistical probability

I would agree with that on OTC stocks but in light of Biogen interest in Anavex compounds and this being a NASDAQ stock..as well as the CEO not having diluted in the past..I think it could be to do with a forthcoming partnership or probable transfer agent fatigue in answering.
icon url

nobrainerstocks

10/29/16 9:02 AM

#78936 RE: Diamondhands45 #78916

Talking about statistical probabilities; how do you see the risk reward ratio here? Must be really low considering current price level, the Biogen tie up and the multiple indications...
icon url

XenaLives

10/29/16 11:13 AM

#78990 RE: Diamondhands45 #78916

"Statistical probability" for OTC - which this is not.

Statistical probability is meaningless here.